Ligand-binding Assays / Immunoassays
360biolabs stands out as a leader in the field of immunoassay development and validation, with extensive expertise across various methodologies to support clinical therapeutic programs. An immunoassay is a bioanalytical technique employed to identify and measure a specific analyte by utilising its binding interactions with antibodies or antigens. The methodologies and platforms utilised for immunoassays can differ considerably based on the analyte, therapeutic approach, and nature of the analytical endpoint.
Expertise With Custom Immunoassay Solutions:
Custom Assay Solutions
Our expert immunology team can provide custom solutions for immunoassay development and validation.
Immunoassay Experts
We can tech transfer, optimise, verify, qualify, or validate an immunoassay in a diverse range of matrices, including disease state.
Speed: Fast Turn Around
Fast data turnaround time to expedite your dose escalation (SAD/MAD) study.
Therapeutic areas
We have experience across a multitude of indications, including but not limited to cardiovascular, pulmonary, immunology and inflammation, metabolic, neurologic, oncology, genetic, autoimmune, and infectious diseases.
Modalities
Large Molecule
Our experience in the large molecule space includes:
- ADC
- Monoclonal antibodies
- Bi-specific/tri-specific proteins
- Enzyme replacements
- Recombinant proteins
Advanced Therapies
Our experience in the advanced therapies space:
- Cell therapy
- Gene therapy
- CAR cell therapy
- RNA-based therapy
- Oligonucleotide therapy
- Stem cell therapy
Vaccines
Our experience in vaccines:
- Inactivated vaccines
- Live-attenuated vaccines
- Messenger RNA (mRNA) vaccines
- Subunit, recombinant, polysaccharide, and conjugate vaccines
- Toxoid vaccines
- Viral vector vaccines